Medtide (HKEX: 03880.HK) is a global CRDMO company specializing in peptides and oligonucleotides. Originally founded as Chinese Peptide Company in 2001, the company has accumulated over 25 years of ...

Completed GMP manufacturing and toxicology milestones supporting planned Q4 2026 IND submission for ulcerative colitisExpanded pipeline strategy ...

Headquartered in Mississauga, Ontario, Diteba is exceptionally well suited to serve as the anchor laboratory for the program, supported by a robust Quality Management System and a multidisciplinary ...

The life science IT market has experienced significant growth owing to growing trend towards laboratory automation, rise in demand for advance analytical tool, and high adoption of life science ...

Neuland secures development collaboration with LIR Life Sciences for transdermal GLP-1CDMO to advance biotech’s novel ...

New treatment target: ProGenis is developing RNA-based drugs to directly improve insulin resistance, tackling a key driver of type 2 diabetes beyond GLP-1 therapies. Onshore manufacturing boost: ...

A Western Australian biotech partnership is developing RNA-based therapies to treat type 2 diabetes by directly improving ...

The main market opportunities lie in providing training for pharmaceutical professionals to enhance their internal GMP audit skills, ensuring compliance with regulatory standards and improving product ...

The "Golden Rules of Being a Successful GMP Auditor (September 30, 2026 and Oct 1, 2026)" training has been added to ResearchAndMarkets.com's offering. Navigating thorough and successful GMP audits ...

A WA biotech duo, ProGenis and Syngenis Laboratories, is developing RNA-based therapies at the next frontier in diabetes ...

Secures long‑term ownership and protection of Link_TSG6, strengthening its global IP position in key markets·         De‑risks development and enhances long‑term value, supporting advancement ...